… ) monitoring of the first and second-line anti-malarial treatments [14] and, in addition, molecular
surveillance of … Artemisinin partial resistance is associated with polymorphisms in the P. …

… for antimalarial drug resistance using TES and molecular monitoring in this region. … Therefore,
we conducted a molecular monitoring study to assess the prevalence of known molecular …

… current prevalence of molecular markers associated with reduced P. … assessment of
polymorphisms in pfcoronin. No mutations … of single nucleotide polymorphisms associated with …

… Hence, there is a need for continuous molecular surveillance of Pfk13 mutations for … single
nucleotide polymorphisms (SNPs) associated with different drug resistance-associated genes …

… artemisinin-based combination therapies (ACTs), poses a significant threat to global malaria
control efforts. Therefore, the close monitoring of molecular … Length Polymorphism was used …

… not associated with artemisinin resistance (24). The data presented in this study are the first
molecular … genes on Bioko Island and assessed the polymorphic profile of the Pfk13 gene. …

… About combination therapy … Artemisinin-based combination therapy (ACT) About
Artemisinin-based combination therapy (ACT) …

… introduction of artemisinin-based combination therapy (ACT) … the instances of pfmdr1
polymorphism while no mutation was … Therefore, continuous monitoring of the molecular markers …

… were genotyped using amplicon sequencing or qPCR for validated markers of anti-malarial
resistance including partner drugs used in artemisinin-based combination therapy (ACT). …

… clearance in patients treated with artemisinin-based combination therapy (ACT) and are, …
large-scale molecular surveillance [10, 11]. k13 SNPs associated with artemisinin resistance …